id: state_rurality_percentage_to_geographic_distance_to_buprenorphine_provider
name: State Rurality Percentage â†’ Geographic Distance to Buprenorphine Treatment Provider
from_node:
  node_id: state_rurality_percentage
  node_name: State Rurality Percentage
to_node:
  node_id: geographic_distance_to_buprenorphine_provider
  node_name: Geographic Distance to Buprenorphine Treatment Provider
direction: positive
category: healthcare_access
mechanism_pathway:
- 'Step 1: Rural areas have lower population density and smaller healthcare workforce
  markets'
- 'Step 2: Buprenorphine prescribing requires special DEA waiver (X-waiver) and training,
  limiting provider pool'
- 'Step 3: Economic incentives and infrastructure support favor provider concentration
  in urban areas'
- 'Step 4: Resulting provider maldistribution creates greater average distances to
  treatment in rural states'
evidence:
  quality_rating: C
  n_studies: 1
  primary_citation: James R Langabeer et al. 2020. "Geographic proximity to buprenorphine
    treatment providers in the U.S.." *Drug and alcohol dependence*. https://doi.org/10.1016/j.drugalcdep.2020.108131
last_updated: '2025-12-02'
version: '1.0'
llm_metadata:
  extracted_by: claude-sonnet-4-5-20250929
  extraction_date: '2025-12-02T18:12:07.499151'
  batch_id: msgbatch_01AKnPJgzm7Fk9qubgAz9GaD
_source_file: /Users/mauriceelhelou/Library/CloudStorage/OneDrive-HarvardUniversity/New
  folder (2)/healthsystems/mechanism-bank/mechanisms/healthcare_access/state_rurality_percentage_to_geographic_distance_to_buprenorphine_provider.yaml
_category: healthcare_access
